English  |  正體中文  |  简体中文  |  2856704  
???header.visitor??? :  53679984    ???header.onlineuser??? :  1764
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"kato k"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 31-42 of 42  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2018-05 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials Chau, I;Chen, LT;Kang, YK;Satoh, T;Kato, K;Chung, HC;Kang, WK;Chao, Y;Chen, JS;Ott, PA;Le, DT;Zhao, HY;Jimenez-Exposito, MJ;Janjigian, YY;Boku, N
國家衛生研究院 2018-02 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials Chau, I;Chen, LT;Kang, YK;Satoh, T;Kato, K;Chung, HC;Kang, WK;Chao, Y;Chen, JS;Ott, PA;Le, DT;Zhao, H;Jimenez-Exposito, MJ;Janjigian, YY;Boku, N
國家衛生研究院 2017-12 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial Kang, YK;Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Chen, LT
國家衛生研究院 2017-09 Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37) Kang, YK;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Boku, N;Chen, LT
國家衛生研究院 2017-09 A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02) Boku, N;Kang, YK;Satoh, T;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Chen, LT
國家衛生研究院 2017-02 Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial Kang, YK;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Boku, N;Chen, LT
臺大學術典藏 2013 A common stomatal parameter set used to simulate the energy and water balance over boreal and temperate forests Yamazaki T.;Kato K.;Ito T.;Nakai T.;Matsumoto K.;Miki N.;Park H.;Ohta T.; Yamazaki T.; Kato K.; Ito T.; Nakai T.; Matsumoto K.; Miki N.; Park H.; Ohta T.; TARO NAKAI
佛光大學 1998-06 ERPs during phonological comparison of Kana-letters involving working memory. Huang K; Kato K; Kobayashi T and Kuriki S
佛光大學 1998 Event-related potentials during comparison of Japanese Kana symbol. In: Hashimoto I, Kakigi R (eds) Recent Advances in Human Neurophysiology. Huang K; Kato K; Kobayashi T and Kuriki S
佛光大學 1997 Dipole localization of ERPs during the comparisons of Japanese Kana-letters. Yamazaki T; Huang K; Kato K; Kobayashi T and Kuriki S
佛光大學 1997 Event-Related Potential during the Comparison of Japanese Kana-letters. Huang K; Kato K; Kobayashi T and Kuriki S
佛光大學 1995 Event-related potential during the comparison of Kana-letters. Huang K; Kato K; Kobayashi T and Kuriki S

Showing items 31-42 of 42  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page